Hims & Hers Health, Inc.HIMS财报
NYSE · 医疗保健 · 服务-医生办公室及诊所
Hims & Hers Health, Inc.是2017年成立的美国远程医疗企业，面向消费者提供处方药品、非处方药物以及各类个人护理产品，依托线上服务模式为用户打造便捷的健康消费渠道，覆盖日常医疗、个护等多场景需求。
营收
$315.6M
毛利润
$256.6M
营业利润
$11.0M
净利润
$13.3M
毛利率
81.3%
营业利润率
3.5%
净利率
4.2%
同比增长
51.8%
EPS
$0.06
资金流向
Hims & Hers Health, Inc. Q2 2024 财务摘要
Hims & Hers Health, Inc. Q2 2024营收 $315.6M（同比增长 51.8%），净利润 $13.3M（同比增长 285.8%）（净利率 4.2%）。销售成本 $59.0M，运营费用 $245.6M。
核心财务指标
| 总营收 | $315.6M |
|---|---|
| 净利润 | $13.3M |
| 毛利率 | 81.3% |
| 营业利润率 | 3.5% |
| 报告期 | Q2 2024 |
营收拆解
Hims & Hers Health, Inc. Q2 2024营收 $315.6M 共来自 2 个业务板块，最大板块 Sales Channel Directly To Consumer 贡献 $306.8M（占 97.2%）。
| 业务分部 | 营收 | 占比 |
|---|---|---|
| Sales Channel Directly To Consumer | $306.8M | 97.2% |
| Sales Channel Through Intermediary | $8.8M | 2.8% |
Hims & Hers Health, Inc. 分部营收 — 季度趋势
Hims & Hers Health, Inc. 过去 4 个季度各业务板块营收走势，展示 Sales Channel Directly To Consumer and Sales Channel Through Intermediary 等业务的变化。
| 业务分部 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Sales Channel Directly To Consumer | — | $589.1M | $536.9M | $576.4M |
| Sales Channel Through Intermediary | — | $9.9M | $8.0M | $9.6M |
Hims & Hers Health, Inc. 年度营收
Hims & Hers Health, Inc. 历年营收汇总，含各年度总量（例如 2025 年营收为 $2.3B）。
| 年份 | 年营收 |
|---|---|
| 2025 | $2.3B |
| 2024 | $1.5B |
| 2023 | $872.0M |
| 2022 | $526.9M |
Hims & Hers Health, Inc. 季度营收与净利润历史
Hims & Hers Health, Inc. 最近 8 个季度的营收、净利润及同比增速
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $617.8M | +28.4% | $20.6M | 3.3% |
| Q3 2025 | $599.0M | +49.2% | $15.8M | 2.6% |
| Q2 2025 | $544.8M | +72.6% | $42.5M | 7.8% |
| Q1 2025 | $586.0M | +110.7% | $49.5M | 8.4% |
| Q4 2024 | $481.1M | +95.1% | $26.0M | 5.4% |
| Q3 2024 | $401.6M | +77.1% | $75.6M | 18.8% |
| Q2 2024 | $315.6M | +51.8% | $13.3M | 4.2% |
| Q1 2024 | $278.2M | +45.8% | $11.1M | 4.0% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $278.2M | $315.6M | $401.6M | $481.1M | $586.0M | $544.8M | $599.0M | $617.8M |
| 同比增长 | 45.8% | 51.8% | 77.1% | 95.1% | 110.7% | 72.6% | 49.2% | 28.4% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $448.1M | $480.5M | $602.3M | $707.5M | $891.7M | $1.88B | $2.23B | $2.15B |
| 总负债 | $103.6M | $118.5M | $162.2M | $230.8M | $342.4M | $1.31B | $1.65B | $1.61B |
| 股东权益 | $344.5M | $362.0M | $440.1M | $476.7M | $549.3M | $562.7M | $581.0M | $540.9M |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $25.8M | $53.6M | $85.3M | $86.4M | $109.1M | $-19.1M | $148.7M | $61.3M |